Get started
Work

Topical steroid withdrawal and atopic dermatitis

Year: 2023
Type: article
Abstract: It is widely accepted and rigorously evidenced that topical corticosteroids (TCS) are effective treatments for atopic dermatitis (AD). Whilst TCS are known to have various adverse effects including skin atrophy, telangiectasia and perioral dermatitis, clear instructions from prescribers on how and where to apply, when to taper or stop use can mitigate these risks, as well as close monitoring by the prescribing clinician before refilling prescriptions. An emphasis on the basics of AD management, such as liberal emollient use, can reduce the requirement for TCS.(1)
DOI: 10.1016/j.anai.2023.12.022
Authors: Hannah F. Marshall, Donald Y.M. Leung, Gideon Lack, Sayantani Sindher, Christina E. Ciaccio, Susan Chan, Kari C. Nadeau, Helen A. Brough
Institutions: National Health Service, Guy's and St Thomas' NHS Foundation Trust, Evelina London Children's Healthcare, National Jewish Health, King's College London, Stanford Medicine, Stanford University, University of Chicago, Harvard University
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,000
OpenAlex ID: W4390127832
FWCI: 5.508
Cites: 8
Cited by: 24
Related to: 10